Generic name: PEGINTERFERON BETA-1A 94ug in 0.5mL; PEGINTERFERON BETA-1A 63ug in 0.5mL
Dosage form: subcutaneous injection
Medically reviewed on June 30, 2017.
PLEGRIDY is administered subcutaneously.
The recommended dosage of PLEGRIDY is 125 micrograms injected subcutaneously every 14 days.
Patients should start treatment with 63 micrograms on day 1. On day 15 (14 days later), the dose is increased to 94 micrograms, reaching the full dose of 125 micrograms on day 29 (after another 14 days). Patients continue with the full dose (125 micrograms) every 14 days thereafter (see Table 1). A PLEGRIDY Starter Pack is available containing two prefilled pens or syringes: 63 micrograms (dose 1) and 94 micrograms (dose 2).
|Dose||Time*||Amount (micrograms)||Color of Pen or
*Dosed every 14 days
|Dose 1||On day 1||63||Orange|
|Dose 2||On day 15||94||Blue|
|Dose 3||On day 29 and every 14 days thereafter||125 (full dose)||Grey|
Important Administration Instructions (All Dosage Forms)
Healthcare professionals should train patients in the proper technique for self-administering subcutaneous injections using the prefilled pen or syringe. Patients should be advised to rotate sites for subcutaneous injections. The usual sites for subcutaneous injections are abdomen, back of the upper arm, and thigh.
Each PLEGRIDY pen and syringe is provided with the needle pre-attached. Prefilled pens and syringes are for a single dose only and should be discarded after use.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Plegridy (peginterferon beta-1a)
- Plegridy Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: interferons
- Plegridy Starter Pack
- Plegridy (Advanced Reading)
- Plegridy Pen (Advanced Reading)
- Plegridy Pen Starter Pack (Advanced Reading)
- Plegridy Starter Pack (Advanced Reading)